Literature DB >> 9152619

Incidence of hyperprolactinemia in patients with Hashimoto's thyroiditis.

K Notsu1, Y Ito, H Furuya, S Ohguni, Y Kato.   

Abstract

The causes of hyperprolactinemia, the correlation between serum levels of PRL and thyroid function and magnetic resonance imaging (MRI) of the pituitary were studied in patients with chronic thyroiditis. Seventy-four female patients and 15 normal control women participated in this clinical survey. Fourteen of 74 patients with various thyroid conditions had increased serum PRL. The incidence of hyperprolactinemia in the overt primary hypothyroid group was 42.4% and was significantly higher than in any other group with normal serum thyroxine. There was a close association between the increment in serum PRL and of free triiodothyronine above the basal level after TRH administration. There were 14 patients with hyperprolactinemia in three of which serum PRL was over 60 micrograms/L. PRL producing tumor, severe primary hypothyroidism and liver cirrhosis were detected in these three patients, respectively. These results indicate that the pathogenesis of increased serum PRL was not uniform in patients with Hashimoto's thyroiditis, although there was a correlation between hyperprolactinemia and impaired thyroid function. It is proposed, therefore, to measure and follow serum levels of PRL and MRI of the pituitary in patients with chronic thyroiditis, especially with impaired thyroid function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9152619     DOI: 10.1507/endocrj.44.89

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  10 in total

1.  Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients.

Authors:  Hedi Orbach; Gisele Zandman-Goddard; Mona Boaz; Nancy Agmon-Levin; Howard Amital; Zoltan Szekanecz; Gabriella Szucs; Josef Rovensky; Emese Kiss; Andrea Doria; Anna Ghirardello; Jesus Gomez-Arbesu; Ljudmila Stojanovich; Francesca Ingegnoli; Pier Luigi Meroni; Blaz' Rozman; Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

2.  Evaluation of serum prolactin level in patients of subclinical and overt hypothyroidism.

Authors:  Parul Goel; Shveta Narang; Bharat K Gupta; Kapil Goel
Journal:  J Clin Diagn Res       Date:  2015-01-01

3.  Increase in Thyrotropin Is Associated with an Increase in Serum Prolactin in Euthyroid Subjects and Patients with Subclinical Hypothyroidism.

Authors:  Vahid Sheikhi; Zahra Heidari
Journal:  Med J Islam Repub Iran       Date:  2021-12-15

4.  Autoimmune hypothyroidism is three times more frequent in female prolactinoma patients compared to healthy women: data from a cross-sectional case-control study.

Authors:  Atanaska Elenkova; Iliana Аtanasova; Georgi Кirilov; Еmil Natchev; Ralitza Ivanova; Roussanka Кovatcheva; Silvia Vandeva; Dimitar Tcharaktchiev; Sabina Zacharieva
Journal:  Endocrine       Date:  2017-07-19       Impact factor: 3.633

5.  Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients.

Authors:  L Vilar; M C Freitas; L A Naves; L A Casulari; M Azevedo; R Montenegro; A I Barros; M Faria; G C Nascimento; J G Lima; L H Nóbrega; T P Cruz; A Mota; A Ramos; A Violante; A Lamounier Filho; M R Gadelha; M A Czepielewski; A Glezer; M D Bronstein
Journal:  J Endocrinol Invest       Date:  2008-05       Impact factor: 4.256

Review 6.  Thyroid disease and male reproductive function.

Authors:  G E Krassas; P Perros
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

7.  Prevalence of autoimmune disease in patients with prolactinomas and non-functioning pituitary adenomas.

Authors:  V Larouche; J A Correa; P Cassidy; C Beauregard; N Garfield; J Rivera
Journal:  Pituitary       Date:  2016-04       Impact factor: 4.107

8.  Severe oligozoospermia in a patient with myxedema coma.

Authors:  Akira Komiya; Akihiko Watanabe; Yoko Kawauchi; Atsuko Takano; Hideki Fuse
Journal:  Reprod Med Biol       Date:  2012-05-09

9.  Morbidity and mortality in patients with hyperprolactinaemia: the PROLEARS study.

Authors:  Enrique Soto-Pedre; Paul J Newey; John S Bevan; Graham P Leese
Journal:  Endocr Connect       Date:  2017-11       Impact factor: 3.335

10.  Reversible thyrotroph hyperplasia with hyperprolactinemia: A rare presenting manifestation of primary hypothyroidism.

Authors:  Rajesh Rajput; Ashish Sehgal; Deepak Gahlan
Journal:  Indian J Endocrinol Metab       Date:  2012-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.